博拓生物：2025年度净利润4679.57万元，同比下降72.39%

Company Performance - Botao Bio reported a revenue of approximately 448 million yuan for the year 2025, representing a year-on-year decrease of 19.85% [1] - The net profit attributable to shareholders was 46.8 million yuan, down 72.39% compared to the previous year [1] - Basic earnings per share were 0.32 yuan, reflecting a decline of 72.17% year-on-year [1] Industry Insights - In February, China's AI usage surpassed that of the United States for the first time, with four major models ranking among the top five globally [1] - The demand for domestic computing power is experiencing exponential growth [1]